Labshake search
Citations for Invivogen :
1 - 50 of 907 citations for Galectin 1 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... these were co-cultured 1:1 in complete RPMI containing OVA peptide (5 mg/mL, InvivoGen) and recombinant TGFβ (1 ng/mL ...
-
bioRxiv - Immunology 2021Quote: ... TRIF inhibitory peptide (InvivoGen) at 25 μM ...
-
bioRxiv - Immunology 2020Quote: ... TRIF inhibitory peptide (InvivoGen) at 25 μM ...
-
bioRxiv - Immunology 2022Quote: OVA323-339 peptide (Invivogen) before analysis.
-
bioRxiv - Immunology 2023Quote: ... whole splenocytes from OT-1 mice were activated with 1 µg/mL OVA 257-264 peptide (InvivoGen) and expanded for 3 days with 200 U/mL rhIL-2 (NCI ...
-
bioRxiv - Immunology 2023Quote: ... whole splenocytes from OT-1 mice were activated with 1 µg/mL OVA 257-264 peptide (InvivoGen) and expanded for 3 days with 200 U/mL rhIL-2 (NCI ...
-
bioRxiv - Immunology 2021Quote: ... and 5μM OVAII peptide (InvivoGen). IL-2 (10ng/mL) ...
-
bioRxiv - Immunology 2020Quote: SIINFEKL peptide (VACSIN) and CpG(tlr-1826-1) were from InvivoGen (San Diego, CA). Neoantigen peptides were purchased from LifeTein (Somerset ...
-
bioRxiv - Neuroscience 2023Quote: ... They were incubated overnight in blocking buffer solution with the primary Anti-mDectin-1-IgG antibody (1:50; cat# mabg-mdect, Invivogen) at 4°C ...
-
bioRxiv - Immunology 2024Quote: ... or by using ovalbumin peptide (OVA257-264, InvivoGen, San Diego, CA, USA; 1 μg/ml), which was loaded on DCs (used at a 3:1 T-to-DC ratio) ...
-
bioRxiv - Immunology 2022Quote: ... peptide M-coupled agarose beads (Invivogen) and Ni Sepharose® Excel Resin (GE Healthcare) ...
-
bioRxiv - Immunology 2022Quote: ... β-glucan-peptide was from Invivogen and dissolved at 5 mg/ml in sterile PBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... OVA peptide (a.a.257-264, InvivoGen) was added at concentration of 5 μg/ml to washed pooled cells and cultured as 5 x 106 cells/ml ...
-
bioRxiv - Microbiology 2020Quote: ... anti-TLR2 blocking antibodies (10μg/ml, Invivogen), or corresponding isotype controls (10μg/ml ...
-
bioRxiv - Immunology 2023Quote: ... whole splenocytes from OT-1 mice were electroporated on day 3 after initial activation with 1 µg/mL OVA 257-264 peptide (InvivoGen), and cells were further expanded for 4 days with 200 U/mL rhIL-2 (NCI) ...
-
bioRxiv - Immunology 2020Quote: ... B-glucan peptide (BGP) 100ug/mL (Invivogen), high mobility group box 1 (HMGB1 ...
-
bioRxiv - Immunology 2022Quote: ... and peptide M-coupled agarose beads (Invivogen), respectively ...
-
bioRxiv - Immunology 2020Quote: ... along with OVA peptide 323-339 (Invivogen) for antigen specific activation ...
-
bioRxiv - Immunology 2022Quote: ... normal rat PAb IgG control blocking antibodies (InvivoGen), Dexamethasone (10µM ...
-
bioRxiv - Immunology 2023Quote: ... Serum flow-through was then passed through 1 mL of Peptide M agarose (InvivoGen, gel-pdm-5) affinity column in gravity mode ...
-
bioRxiv - Immunology 2022Quote: ... Mice were infected intranasally with 3×104 PFU of x31-PmpG-1 virus and boosted intranasally with 1μg PmpG-1303-311 peptide + 2μg CpG (ODN 1826, Invivogen) on days 14 and 28 (75) ...
-
bioRxiv - Microbiology 2020Quote: ... and Peptide M / Agarose (InvivoGen, San Diego, CA), respectively ...
-
bioRxiv - Immunology 2023Quote: ... total IgA purified on Peptide M-agarose (Invivogen) was incubated with M-280 Streptavidin Dynabeads coated with 10 µg biotinylated TG2 or TG3 ...
-
bioRxiv - Immunology 2022Quote: ... 2×104 DCs were co-cultured for 3 days with 5×104 FACS sorted naïve OT-II CD4+ T cells in the presence of 1 µg/ml OVA peptide (OVA323-339, Invivogen) and 0.25 ng/ml TGFβ (recombinant mouse TGF-b1 ...
-
Mapping of the autophagosomal degradome identifies IL-7Rα as key cargo in proliferating CD4+ T-cellsbioRxiv - Immunology 2021Quote: ... total splenocytes isolated from OT-II mouse spleens were cultured with OVA 323-339 peptide (1 mg/ml, InvivoGen) and recombinant murine IL-2 (20 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... Flow through sera was then applied to a gravity flow column containing 1 mL Peptide M-sepharose resin (InvivoGen) to purify IgA ...
-
bioRxiv - Cell Biology 2022Quote: ... β-glucan peptide (Invivogen, tlrl-bn, ant-zn-05), Hygromycin B (Invivogen ...
-
bioRxiv - Cell Biology 2020Quote: ... Host mice were immunized subcutaneously in the hock area (50 μL each site) in both legs with 1 mg/mL OVA323-339 peptide (InvivoGen) emulsified with CFA (InvivoGen) ...
-
bioRxiv - Immunology 2022Quote: ... Host mice were immunized subcutaneously in the hock area (10 μL each site) in both legs with 1 mg/mL OVA323–339 peptide (InvivoGen) emulsified with CFA (InvivoGen) ...
-
bioRxiv - Immunology 2022Quote: ... Host mice were immunized subcutaneously in the hock area (50 μL each site) in both legs with 1 mg/mL OVA323-339 peptide (InvivoGen) emulsified with CFA (InvivoGen) ...
-
bioRxiv - Immunology 2021Quote: ... host mice were immunized subcutaneously in the hock area of both legs with 50 μL OVA323-339 peptides (1 mg/mL, InvivoGen) emulsified with complete Freund’s adjuvant (CFA ...
-
bioRxiv - Immunology 2020Quote: ... 300µl of plasma was diluted with PBS heat-inactivated (56°C for 1 hr) and incubated with peptide M/Agarose (Invivogen) or Protein G/Agarose (GE lifeSciences ...
-
The T-cell niche tunes immune function through modulation of the cytoskeleton and TCR-antigen forcesbioRxiv - Bioengineering 2024Quote: ... OT-1 T-cells (5 × 104 cells/well) were co-cultured with 0.5 ng/mL SIINFEKL peptide (InVivoGen, # vac-sin)-pulsed splenocytes (5 × 104 cells/well ...
-
bioRxiv - Immunology 2020Quote: ... clarified by centrifugation and subsequently incubated with Peptide M(Invivogen)/Protein G-coupled sepharose beads (Invivogen ...
-
bioRxiv - Immunology 2023Quote: ... variable regions and leader peptides were cloned into pVITRO1 (Invivogen) plasmids that contained the constant regions for mouse IgG1 κ heavy and light chains using Gibson Assembly75 ...
-
bioRxiv - Immunology 2022Quote: ... OT-I splenocytes were treated with 10μg/ml SIINFEKL peptide (Invivogen) for 16h ...
-
bioRxiv - Cancer Biology 2023Quote: ... or with 5 ug/ml OVA peptide (a.a.257-264, InvivoGen) for 4-5 hr in the presence of Golgi Stop (1/1000 ...
-
bioRxiv - Cell Biology 2020Quote: ... OT-II peptide OVA323-339 (ISQAVHAAHAEINEAGR) was from InvivoGen (San Diego, CA) and kindly provided by Paula Oliver (Children’s Hospital of Philadelphia ...
-
bioRxiv - Bioengineering 2020Quote: ... OVA 257-264 (SIINFEKL peptides) was purchased from InvivoGen (San Diego, CA, USA). Amine-terminated GGGGRGDSP (G4RGDSP ...
-
bioRxiv - Immunology 2019Quote: ... TRIF peptide inhibitor was used at a final concentration of 25 μM (Invivogen). Actinomycin D (Sigma ...
-
bioRxiv - Immunology 2022Quote: ... Sorted tumor APC populations were pulsed with 0.01 ng/mL SIINFEKL peptide (Invivogen) at 37°C for 1.25 hours and then washed twice.
-
bioRxiv - Microbiology 2022Quote: ... 20 µl of 10 µg/ml β-glucan peptides (Invivogen; catalog #tlrl-bgp), 20 µl of β-glucan peptides + Piceatannol (250nM ...
-
The T-cell niche tunes immune function through modulation of the cytoskeleton and TCR-antigen forcesbioRxiv - Bioengineering 2024Quote: ... Blinatumomab (# bimab-hcd19cd3) and SIINFEKL-OVA peptide (# vac-sin) were purchased from InVivoGen. Cupric Sulfate ...
-
bioRxiv - Bioengineering 2020Quote: ... cells were incubated with 10 nM chicken egg ovalbumin peptide 257-264 (SIINFEKL, Invivogen) with or without 1000 IU/mL IL-2 (or equimolar amounts modified protein ...
-
bioRxiv - Immunology 2023Quote: ... cells were incubated for 2 hours with or without TLR2 blocking antibody (Invivogen cat.# mab2-mtlr2) followed by incubation with CEP or Pam3CSK4 (Invivogen cat.# tlrl-pms ...
-
bioRxiv - Immunology 2022Quote: ... total IgA was purified from saliva using Peptide M/agarose (InvivoGen Inc., San Diego, CA, USA) and used for the neutralization at low-dilution (1:2-1:10) ...
-
bioRxiv - Microbiology 2021Quote: Human IgA was purified from fecal supernatants with Peptide M/ Agarose (InvivoGen, Cat. No. gel-pdm-2) as described by the manufacturer ...
-
bioRxiv - Cancer Biology 2022Quote: ... and MHC-I blocking antibody (W6/32; 50 ug/ml) in RPMI supplemented with human serum and primocin (Invivogen). Cells were harvested and stained with anti-CD3 FITC antibody (UCHT1 ...
-
bioRxiv - Bioengineering 2024Quote: The ability of 1V209-modified peptides to activate TLR7 was assessed using HEK-Blue mTLR7 reporter cells (InvivoGen) using the standard protocol provided by the supplier ...
-
bioRxiv - Systems Biology 2020Quote: Monocyte-derived DCs were pre-treated with blocking Abs as described above for one hour and then cultured with medium or LPS (100 ng/mL, Invivogen) for an additional 4 or 8 hours ...